Arcalyst

Kiniksa inks licensing deal to take a Regeneron castoff into Asian markets
Endpoints
Wed, 02/23/22 - 10:31 am
Kiniksa Pharmaceuticals
Regeneron
Arcalyst
Huadong Medicine
Asia
mavrilimumab
Kiniksa preps BLA as Regeneron drug cruises to a PhIII win — shares soar
Endpoints
Mon, 06/29/20 - 10:07 am
Kiniksa Pharmaceuticals
Regeneron
Arcalyst
pericarditis
clinical trials
Why Regeneron Pharmaceuticals Has A Bright Future Ahead
Seeking Alpha
Tue, 02/11/14 - 08:52 am
Regeneron
Arcalyst
Eylea
Zaltrap
3 Drugs Approved, but Only 1 Matters
Motley Fool
Tue, 08/7/12 - 11:43 am
FDA
drug approvals
Regeneron
Arcalyst
Eyelea
Novartis
Sanofi
Zaltrap
FDA rejects expanded use of Regeneron drug for gout
Reuters
Tue, 07/31/12 - 11:06 am
Regeneron
gout
FDA
Arcalyst
Vivus, Onyx, Amarin Await Key Dates in July
Minyanville
Tue, 07/3/12 - 11:43 am
Amarin
ONYX Pharmaceuticals
Vivus
Qnexa
AMR101
Arcalyst
Regeneron
Kyprolis
Salix
Relistor
Progenics Pharmaceuticals
Rayos
Roche
Lucentis
Horizon Pharma
Regeneron: FDA panel says no to Arcalyst for gout
Yahoo/AP
Tue, 05/8/12 - 07:19 pm
FDA
Arcalyst
gout
Regeneron
Pfizer, Gilead Sciences, Arena Pharmaceuticals Face Big Dates in May
Minyanville
Mon, 04/30/12 - 10:12 pm
Pfizer
Arena Pharmaceuticals
Gilead Sciences
Vyndaqel
JNJ
Xarelto
ASCO
Talon Therapeutics
Marqibo
Quad
Truvada
lorcaserin
Protalix BioTherapeutics
Alexza
Adasuve
Arcalyst
Regeneron
Abbott Laboratories
Remicade
6 Biotech Stocks With Huge Potential In May
Seeking Alpha
Wed, 04/11/12 - 10:56 am
taliglucerase alfa
Protalix BioTherapeutics
Alexza
Adasuve
Regeneron
Arcalyst
lorcaserin
Arena Pharmaceuticals
Quad
Truvada
Gilead
Talon Therapeutics
Marqibo
Regeneron Announces Strong Results In Gout Study
Forbes
Mon, 02/28/11 - 12:26 pm
gout
Regeneron
Arcalyst
The Drug Passed, but the Stock Fell?
Motley Fool
Thu, 06/10/10 - 09:22 am
Regeneron
gout
Arcalyst